P3.13C.02 A Plasma Proteomics-Based Model for Clinical Benefit Prediction in Small Cell Lung Cancer Patients Receiving Immunotherapy
Year: 2024
Type: article
Source: Journal of Thoracic Oncology
Authors: D.R. Gandara, D.P. Carbone, A.P. Dicker, P. Christopoulos, I. Puzanov, P. Jain, D. Farrugia, S. Brown, M. Moskovitz, J. Bar, A. Hassani, A. Chatterjee, M. Abu-Amna, A. Polychronis, A. Brewster, Y. Lou, N.A. VanderWalde, M. Gottfried, C. Lahav, G. Lowenthal, I. Sela, M. Harel, Y. Elon, M.A. Schneider
Institutions: University of California Davis Medical Center, The Ohio State University, Thomas Jefferson University, Roswell Park Comprehensive Cancer Center, Cheltenham General Hospital, Rabin Medical Center, Sheba Medical Center, South Tyneside District Hospital, Sunderland Royal Hospital, Shrewsbury and Telford Hospital NHS Trust, Emek Medical Center, Mount Vernon Cancer Centre, Withybush General Hospital, Mayo Clinic in Florida, Meir Medical Center, University Hospital Heidelberg
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4403420354